Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas

Purpose: Glioblastoma (GBM) remains an incurable disease despite extensive treatment with surgical resection, irradiation, and temozolomide. In line with many other forms of aggressive cancers, GBM is currently under consideration as a target for immunotherapy. However, GBM tends to be nonimmunogeni...

Full description

Bibliographic Details
Main Authors: Jean Philippe Nesseler, MD, Dorthe Schaue, PhD, William H. McBride, PhD, DSc, Mi-Heon Lee, PhD, Tania Kaprealian, MD, Simone P. Niclou, PhD, Philippe Nickers, MD, PhD
Format: Article
Language:English
Published: Elsevier 2019-04-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109418302380

Similar Items